Acid reflux detection and symptom-reflux association using 4-day wireless pH recording combining 48-hour periods off and on PPI therapy

American Journal of Gastroenterology

Volumn 103, Issue 7, 2008, Pages 1631-1637

  Garrean, Carol P ^a   Zhang, Qing ^a   Gonsalves, Nirmala ^a   Hirano, Ikuo ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

OMEPRAZOLE; RABEPRAZOLE; 2 [[(2 PYRIDYL)METHYL]SULFINYL]BENZIMIDAZOLE DERIVATIVE; BICARBONATE; PROTON PUMP INHIBITOR;

ADULT; AGED; ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DRUG EFFECT; ESOPHAGUS PH; FEMALE; GASTRIC PH MONITORING; GASTROESOPHAGEAL REFLUX; HUMAN; MAJOR CLINICAL STUDY; MALE; PH MEASUREMENT; PRIORITY JOURNAL; ESOPHAGEAL PH MONITORING; MIDDLE AGED; PATHOPHYSIOLOGY; SENSITIVITY AND SPECIFICITY;

2-PYRIDINYLMETHYLSULFINYLBENZIMIDAZOLES; ADULT; AGED; AGED, 80 AND OVER; ESOPHAGEAL PH MONITORING; FEMALE; GASTROESOPHAGEAL REFLUX; HUMANS; MALE; MIDDLE AGED; OMEPRAZOLE; PROTON PUMP INHIBITORS; SENSITIVITY AND SPECIFICITY; SODIUM BICARBONATE;

EID: 50649098297     PISSN: 00029270     EISSN: 15720241     Source Type: Journal    
DOI: 10.1111/j.1572-0241.2008.01829.x     Document Type: Article

References (21)

1. Johnsson F, Joelsson B. Reproducibility of ambulatory oesophageal pH monitoring. Gut 1988;29:886-9.
2. Wiener GJ, Morgan TM, Copper JB, et al. Ambulatory 24-hour esophageal pH monitoring. Reproducibility and variability of pH parameters. Dig Dis Sci 1988;33:1127-33.
3. Ahlawat SK, Novak DJ, Williams DC, et al. Day-to-day variability in acid reflux patterns using the BRAVO pH monitoring system. J Clin Gastroenterol 2006;40:20-4.
4. Pandolfino JE, Richter JE, Ours T, et al. Ambulatory esophageal pH monitoring using a wireless system. Am J Gastroenterol 2003;98:740-9.
5. Prakash C, Clouse RE. Value of extended recording time with wireless pH monitoring inevaluating gastroesophageal reflux disease. Clin Gastroenterol Hepatol 2005;3:329-34.
6. Hirano I, Richter JE. ACG practice guidelines: Esophageal reflux testing. Am J Gastroenterol 2007;102:668-85.
7. Kahrilas PJ, Quigley EM, Clinical esophageal pH recording: a technical review for practice guideline development. Gastroenterology 1996;110(6):1982-96.
8. Milkes D, Gerson LB, Triadafilopoulos G. Complete elimination of reflux symptoms does not guarantee normalization of intraesophageal and intragastric pH in patients with gastroesophageal reflux disease (GERD). Am J Gastroenterol 2004;99:991-6.
9. Katzka DA, Paoletti V, Leite L, et al. Prolonged ambulatory pH monitoring in patients with persistent gastroesophageal reflux disease symptoms: Testing while on therapy identifies the need for more aggressive anti-reflux therapy. Am J Gastroenterol 1996;91:2110-3.
10. Fass R, Fennerty MB, Ofman JJ, et al. The clinical and economic value of a short course of omeprazole in patients with noncardiac chest pain. Gastroenterology 1998;115:42-9.
11. Zerbib F, Roman S, Ropert A, et al. Esophageal pH- impedance monitoring and symptom analysis in GERD: A study in patients off and on therapy. Am J Gastroenterol 2006;101:1956-63.
12. Sifrim D, Castell D, Dent J, et al. Gastro-oesophageal reflux monitoring: Review and consensus report on detection and definitions of acid, non-acid, and gas reflux. Gut 2004;53:1024-31.
13. Mainie I, Tutuian R, Shay S, et al. Acid and non-acid reflux in patients with persistent symptoms despite acid suppressive therapy: A multicentre study using combined ambulatory impedance-pH monitoring. Gut 2006;55:1398-402.
14. Hirano I, Zhang Q, Pandolfino JE, et al. Four-day Bravo pH capsule monitoring with and without proton pump inhibitor therapy. Clin Gastroenterol Hepatol 2005;3:1083-8.
15. Wiener GJ, Richter JE, Copper JB, et al. The symptom index: A clinically important parameter of ambulatory 24-hour esophageal pH monitoring. Am J Gastroenterol 1988;83:358-61.
16. Breumelhof R, Smout AJ. The symptom sensitivity index: A valuable additional parameter in 24-hour esophageal pH recording. Am J Gastroenterol 1991;86:160-4.
17. Weusten BL, Roelofs JM, Akkermans LM, et al. The symptom-association probability: An improved method for symptomanalysis of 24-houresophagealpHdata. Gastroen- terology 1994;107:1741-5.
18. Prakash C, Clouse RE. Wireless pH monitoring in patients with non-cardiac chest pain. Am J Gastroenterol 2006;101:446-52.
19. Taghavi SA, Ghasedi M, Saberi-Firoozi M, et al. Symptom association probability and symptom sensitivity index: Preferable but still suboptimal predictors ofresponse to high dose omeprazole. Gut 2005;54:1067-71.
20. Bredenoord AJ, Weusten BL, Timmer R, et al. Addition of esophageal impedance monitoring to pH monitoring increases the yield of symptom association analysis in patients off PPI therapy. Am J Gastroenterol 2006;101:453-9.
21. Nguyen HN, Silny J, Matern S. Multiple intraluminal electrical impedancometry for recording of upper gastrointestinal motility: Current results and further implications. Am J Gastroenterol 1999;94:306-17.